ArticleBMC public health2025
Mediators of the association between rheumatoid arthritis and depression.
Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
objectiveThe etiology of rheumatoid arthritis (RA) comorbid with depression is poorly defined. This study aims to investigate the mediating factors in RA co-morbid depression.
methodsThrough the multicenter, cross-sectional study method, the variables that may become mediating factors were collected. Depression was assessed with the Patient Health Questionnaire-9 (PHQ-9). The generalized linear model and Structural Equation Model (SEM) were used to explore the mediators. Mendelian randomization (MR) was employed to validate the results.
resultsA total of 746 subjects were enrolled, including 506 RA patients and 240 non-RA patients. Correlation analysis showed that Health assessment questionnaire disability index (HAQ-DI) (β = 0.04; 95%CI = 0.01, 0.07; P = 0.002), Fatigue Self-Assessment Scale (FSAS) (β = 0.21; 95%CI = 0.19, 0.23; P < 0.0001), and Pittsburgh sleep quality index (PSQI) (β = 0.26; 95%CI = 0.19, 0.33; P < 0.0001) were positively correlated with RA co-morbid depression. Among these, FSAS was a mediator in the causal pathway from RA to depression (Effect estimate = 0.39; 95% CI = 0.30, 0.53). MR analysis supports the mediating role of frailty. In addition, HAQ-DI indirectly mediated the effect of RA on depression through a sequential pathway involving ESR and FSAS, serving as another key factor in this causal pathway.
conclusionFatigue and disability are primary mediators contributing to the comorbidity of RA and depression. Therefore, targeting these mediating factors through clinical interventions may represent an effective strategy for preventing and treating depression in this population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.